Stay updated on Entinostat + Pembrolizumab in Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T13:50:57.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study content with a generic error page. This indicates that access to the NCT03179930 study record is blocked, with the error text visible on the page.
    Difference
    18%
    Check dated 2026-09-20T15:46:12.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page's revision label in the footer updated from v3.6.5 to v3.6.6, signaling a newer build of the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-08-29T23:58:18.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The bottom of the page shows a revision stamp updated from v3.6.4 to v3.6.5, indicating a minor template or deployment update. This appears to be a routine system update rather than a change to study information.
    Difference
    0.1%
    Check dated 2026-08-08T22:54:13.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page now shows a new revision tag (v3.6.4) and additional date entries, replacing the prior revision tag (v3.6.3). This indicates a maintenance/update to the page rather than changes to the study data.
    Difference
    0.4%
    Check dated 2026-07-25T12:35:48.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The revision label on the page now shows v3.6.3, replacing the prior v3.6.2. This indicates a new revision of the study record.
    Difference
    0.1%
    Check dated 2026-07-03T23:23:29.000Z thumbnail image

Stay in the know with updates to Entinostat + Pembrolizumab in Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.